한글목차

파지 요법 시장은 2023-2028년간 5,100만 달러 확대되고, 예측 기간 중 연평균 복합 성장률(CAGR)은 17.41%를 나타낼 것으로 예측됩니다.

파지 요법 시장에 대한 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 게재했습니다.

현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공합니다. 항생제와 비교한 파지 요법의 장점, 동물 건강에 대한 파지 요법 용도 증가, 인간 건강에 대한 파지 요법 용도 증가가 시장 성장을 가속하고 있습니다.

본 조사에서는 향후 몇 년간 파지 요법 시장 성장을 가속하는 주요인 중 하나로서 파지 요법에 대한 투자 증가를 들고 있습니다. 또한 파지 요법 임상시험 증가나 벤더간 파트너십 증가가 시장의 큰 수요로 연결될 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 구도

• 시장 생태계

제3장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모(2023년)
• 시장 전망(2023-2028년)

제4장 시장 규모 실적

• 세계의 파지 요법 시장(2018-2022년)
• 제품별 부문 분석(2018-2022년)
• 용도별 부문 분석(2018-2022년)
• 지역별 부문 분석(2018-2022년)
• 국가별 부문 분석(2018-2022년)

제5장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁 위협
• 시장 현황

제6장 시장 세분화 : 제품별

• 시장 부문
• 비교 : 제품별
• 대장균 : 시장 규모와 예측(2023-2028년)
• 황색포도상구균 : 시장 규모와 예측(2023-2028년)
• 살모네라균 : 시장 규모와 예측(2023-2028년)
• 기타 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 제품별

제7장 시장 세분화 : 용도별

• 시장 부문
• 비교 : 용도별
• 동물 건강 : 시장 규모와 예측(2023-2028년)
• 식품 업계 : 시장 규모와 예측(2023-2028년)
• 수산양식 등 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 용도별

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 유럽 : 시장 규모와 예측(2023-2028년)
• 북미 : 시장 규모와 예측(2023-2028년)
• 아시아 : 시장 규모와 예측(2023-2028년)
• 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
• 미국 : 시장 규모와 예측(2023-2028년)
• 중국 : 시장 규모와 예측(2023-2028년)
• 폴란드 : 시장 규모와 예측(2023-2028년)
• 캐나다 : 시장 규모와 예측(2023-2028년)
• 영국 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 지역 상황별

제10장 성장 촉진요인, 과제 및 동향

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 성장 촉진요인과 과제의 영향
• 시장 동향

제11장 벤더 구도

• 개요
• 벤더 구도
• 혼란 상황
• 업계 리스크

제12장 벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• Adaptive Phage Therapeutics
• APS Biocontrol Ltd.
• Armata Pharmaceuticals Inc.
• CJ CheilJedang Corp.
• Cytophage Technologies Inc.
• Intralytix Inc.
• iNtRON Biotechnology Inc.
• JSC NPO Microgen
• Locus Biosciences Inc.
• Micreos
• Micromir
• Nexabiome
• Proteon Pharmaceuticals S.A.
• TechnoPhage
• ZeptoMetrix LLC

제13장 부록

영문목차

The phage therapy market is forecasted to grow by USD 51 mn during 2023-2028, accelerating at a CAGR of 17.41% during the forecast period. The report on the phage therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by benefits of phage therapy over antibiotics, increasing application of phage therapy for animal health, and increasing application of phage therapy for human health.

Technavio's phage therapy market is segmented as below:

By Product

• Escherichia coli
• Staphylococcus aureus
• Salmonella
• Others

By Application

• Animal health
• Food industry
• Others

By Geographical Landscape

• Europe
• North America
• Asia
• Rest of World (ROW)

This study identifies the increasing investments in phage therapy as one of the prime reasons driving the phage therapy market growth during the next few years. Also, increasing clinical trials for phage therapy and increasing number of partnerships among vendors will lead to sizable demand in the market.

The report on the phage therapy market covers the following areas:

• Phage therapy market sizing
• Phage therapy market forecast
• Phage therapy market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading phage therapy market vendors that include Adaptive Phage Therapeutics, APS Biocontrol Ltd., Armata Pharmaceuticals Inc., Astellas Pharma Inc., BiomX Inc., CJ CheilJedang Corp., Cytophage Technologies Inc., Eliava Biopreparation LLC, Intralytix Inc., iNtRON Biotechnology Inc., JSC NPO Microgen, Locus Biosciences Inc., Micreos, Micromir, Nexabiome, Proteon Pharmaceuticals S.A., Taconic Biosciences Inc., TechnoPhage, ZeptoMetrix LLC, and Vitalis Wellness LLP. Also, the phage therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global phage therapy market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global phage therapy market 2018 - 2022 ($ million)
• 4.2 Product Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
• 4.3 Application Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

• 6.1 Market segments
• Exhibit 30: Chart on Product - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
• 6.2 Comparison by Product
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product
• 6.3 Escherichia coli - Market size and forecast 2023-2028
• Exhibit 34: Chart on Escherichia coli - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Escherichia coli - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Escherichia coli - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Escherichia coli - Year-over-year growth 2023-2028 (%)
• 6.4 Staphylococcus aureus - Market size and forecast 2023-2028
• Exhibit 38: Chart on Staphylococcus aureus - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on Staphylococcus aureus - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on Staphylococcus aureus - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Staphylococcus aureus - Year-over-year growth 2023-2028 (%)
• 6.5 Salmonella - Market size and forecast 2023-2028
• Exhibit 42: Chart on Salmonella - Market size and forecast 2023-2028 ($ million)
• Exhibit 43: Data Table on Salmonella - Market size and forecast 2023-2028 ($ million)
• Exhibit 44: Chart on Salmonella - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Salmonella - Year-over-year growth 2023-2028 (%)
• 6.6 Others - Market size and forecast 2023-2028
• Exhibit 46: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 48: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 49: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 6.7 Market opportunity by Product
• Exhibit 50: Market opportunity by Product ($ million)
• Exhibit 51: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Application

• 7.1 Market segments
• Exhibit 52: Chart on Application - Market share 2023-2028 (%)
• Exhibit 53: Data Table on Application - Market share 2023-2028 (%)
• 7.2 Comparison by Application
• Exhibit 54: Chart on Comparison by Application
• Exhibit 55: Data Table on Comparison by Application
• 7.3 Animal health - Market size and forecast 2023-2028
• Exhibit 56: Chart on Animal health - Market size and forecast 2023-2028 ($ million)
• Exhibit 57: Data Table on Animal health - Market size and forecast 2023-2028 ($ million)
• Exhibit 58: Chart on Animal health - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Animal health - Year-over-year growth 2023-2028 (%)
• 7.4 Food industry - Market size and forecast 2023-2028
• Exhibit 60: Chart on Food industry - Market size and forecast 2023-2028 ($ million)
• Exhibit 61: Data Table on Food industry - Market size and forecast 2023-2028 ($ million)
• Exhibit 62: Chart on Food industry - Year-over-year growth 2023-2028 (%)
• Exhibit 63: Data Table on Food industry - Year-over-year growth 2023-2028 (%)
• 7.5 Aquaculture and others - Market size and forecast 2023-2028
• Exhibit 64: Chart on Aquaculture and others - Market size and forecast 2023-2028 ($ million)
• Exhibit 65: Data Table on Aquaculture and others - Market size and forecast 2023-2028 ($ million)
• Exhibit 66: Chart on Aquaculture and others - Year-over-year growth 2023-2028 (%)
• Exhibit 67: Data Table on Aquaculture and others - Year-over-year growth 2023-2028 (%)
• 7.6 Market opportunity by Application
• Exhibit 68: Market opportunity by Application ($ million)
• Exhibit 69: Data Table on Market opportunity by Application ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 73: Chart on Geographic comparison
• Exhibit 74: Data Table on Geographic comparison
• 9.3 Europe - Market size and forecast 2023-2028
• Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.4 North America - Market size and forecast 2023-2028
• Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 China - Market size and forecast 2023-2028
• Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.9 Poland - Market size and forecast 2023-2028
• Exhibit 99: Chart on Poland - Market size and forecast 2023-2028 ($ million)
• Exhibit 100: Data Table on Poland - Market size and forecast 2023-2028 ($ million)
• Exhibit 101: Chart on Poland - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on Poland - Year-over-year growth 2023-2028 (%)
• 9.10 Canada - Market size and forecast 2023-2028
• Exhibit 103: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibit 104: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibit 105: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibit 106: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.11 UK - Market size and forecast 2023-2028
• Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 111: Market opportunity By Geographical Landscape ($ million)
• Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 113: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 115: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 116: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 117: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 118: Matrix on vendor position and classification
• 12.3 Adaptive Phage Therapeutics
• Exhibit 119: Adaptive Phage Therapeutics - Overview
• Exhibit 120: Adaptive Phage Therapeutics - Product / Service
• Exhibit 121: Adaptive Phage Therapeutics - Key offerings
• 12.4 APS Biocontrol Ltd.
• Exhibit 122: APS Biocontrol Ltd. - Overview
• Exhibit 123: APS Biocontrol Ltd. - Product / Service
• Exhibit 124: APS Biocontrol Ltd. - Key offerings
• 12.5 Armata Pharmaceuticals Inc.
• Exhibit 125: Armata Pharmaceuticals Inc. - Overview
• Exhibit 126: Armata Pharmaceuticals Inc. - Product / Service
• Exhibit 127: Armata Pharmaceuticals Inc. - Key offerings
• 12.6 CJ CheilJedang Corp.
• Exhibit 128: CJ CheilJedang Corp. - Overview
• Exhibit 129: CJ CheilJedang Corp. - Business segments
• Exhibit 130: CJ CheilJedang Corp. - Key offerings
• Exhibit 131: CJ CheilJedang Corp. - Segment focus
• 12.7 Cytophage Technologies Inc.
• Exhibit 132: Cytophage Technologies Inc. - Overview
• Exhibit 133: Cytophage Technologies Inc. - Product / Service
• Exhibit 134: Cytophage Technologies Inc. - Key offerings
• 12.8 Intralytix Inc.
• Exhibit 135: Intralytix Inc. - Overview
• Exhibit 136: Intralytix Inc. - Product / Service
• Exhibit 137: Intralytix Inc. - Key offerings
• 12.9 iNtRON Biotechnology Inc.
• Exhibit 138: iNtRON Biotechnology Inc. - Overview
• Exhibit 139: iNtRON Biotechnology Inc. - Product / Service
• Exhibit 140: iNtRON Biotechnology Inc. - Key offerings
• 12.10 JSC NPO Microgen
• Exhibit 141: JSC NPO Microgen - Overview
• Exhibit 142: JSC NPO Microgen - Product / Service
• Exhibit 143: JSC NPO Microgen - Key offerings
• 12.11 Locus Biosciences Inc.
• Exhibit 144: Locus Biosciences Inc. - Overview
• Exhibit 145: Locus Biosciences Inc. - Product / Service
• Exhibit 146: Locus Biosciences Inc. - Key offerings
• 12.12 Micreos
• Exhibit 147: Micreos - Overview
• Exhibit 148: Micreos - Product / Service
• Exhibit 149: Micreos - Key offerings
• 12.13 Micromir
• Exhibit 150: Micromir - Overview
• Exhibit 151: Micromir - Product / Service
• Exhibit 152: Micromir - Key offerings
• 12.14 Nexabiome
• Exhibit 153: Nexabiome - Overview
• Exhibit 154: Nexabiome - Product / Service
• Exhibit 155: Nexabiome - Key offerings
• 12.15 Proteon Pharmaceuticals S.A.
• Exhibit 156: Proteon Pharmaceuticals S.A. - Overview
• Exhibit 157: Proteon Pharmaceuticals S.A. - Product / Service
• Exhibit 158: Proteon Pharmaceuticals S.A. - Key offerings
• 12.16 TechnoPhage
• Exhibit 159: TechnoPhage - Overview
• Exhibit 160: TechnoPhage - Product / Service
• Exhibit 161: TechnoPhage - Key offerings
• 12.17 ZeptoMetrix LLC
• Exhibit 162: ZeptoMetrix LLC - Overview
• Exhibit 163: ZeptoMetrix LLC - Product / Service
• Exhibit 164: ZeptoMetrix LLC - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 165: Inclusions checklist
• Exhibit 166: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 167: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 168: Research methodology
• Exhibit 169: Validation techniques employed for market sizing
• Exhibit 170: Information sources
• 13.5 List of abbreviations
• Exhibit 171: List of abbreviations